(Total Views: 390)
Posted On: 09/13/2019 11:19:55 AM
Post# of 149459
Really really hope they never do a RS. Hoping the price goes up organically, but if they do something and it is near a dollar, I hope they do nothing but a 2 to 1.. an 8 to 1 or what they were talking about last time, is definitely not something I would like.
Fully deluted at 700M shares -
Combo - 2.3 billion $3.29 a share from past figures
Mono - 5 billion $7.14 a share from past figures
NASH - 87.5 Billion $125 dollars a share - Estimated 3 to 12% of population of the US only suffers from NASH - Seems high, maybe I am missing something? But if anyone has anything more to add, add it and repost that.
Low end of the spectrum 10 million patients in the US alone @ 3% of 327million people - No cure at the moment - Leronlimab possibly only answer - 350 Billion dollar market at 3% - Figure at least 50% receiving medical treatment for it. 175 Billion dollar potential a year @ current discussed Leronlimab price - 35k a year/50% royalties for licensing - 87.5 Billion -
Cancer - ???? Crazy amounts!!!
This is why I laugh when someone says 2 dollars..
Fully deluted at 700M shares -
Combo - 2.3 billion $3.29 a share from past figures
Mono - 5 billion $7.14 a share from past figures
NASH - 87.5 Billion $125 dollars a share - Estimated 3 to 12% of population of the US only suffers from NASH - Seems high, maybe I am missing something? But if anyone has anything more to add, add it and repost that.
Low end of the spectrum 10 million patients in the US alone @ 3% of 327million people - No cure at the moment - Leronlimab possibly only answer - 350 Billion dollar market at 3% - Figure at least 50% receiving medical treatment for it. 175 Billion dollar potential a year @ current discussed Leronlimab price - 35k a year/50% royalties for licensing - 87.5 Billion -
Cancer - ???? Crazy amounts!!!
This is why I laugh when someone says 2 dollars..
(4)
(0)Scroll down for more posts ▼
